PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 31 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

4 October 2025

  1. (diff | hist) 13:19 GL Biochem (Shanghai) 16,271 +931 MolarMassMaeve (talk | contribs) add category for suppliers in China [rollback]
  2. (diff | hist) 08:39 Talk:Beyond-use date 1,444 +100 UnitAuditUwe (talk | contribs) /* Date arithmetic: inclusive or exclusive? */ reply
  3. (diff | hist) 07:33 Fmoc chemistry 4,618 ±0 GastroparesisGwen (talk | contribs) rm the shipping recommendation — that is advice, not description [rollback]
  4. (diff | hist) 04:37 Xi'an Mokemei Biotechnology 11,462 +902 BetaCellBoyd (talk | contribs) de-orphan [rollback]
  5. (diff | hist) m b 01:50 Patent expiry and biosimilars 4,553 +370 ArchiveBot (talk | contribs) bot: expand DOI to full citation [rollback]
  6. (diff | hist) 01:02 Qingdao Saber Technology Pharmaceutical 7,658 +109 IncretinIvo (talk | contribs) state the city and province of the registered address [rollback]

3 October 2025

  1. (diff | hist) m 20:22 PolyPeptide Group (Hangzhou) 6,300 +33 VerifyVesna (talk | contribs) label the reception tally as weak, self-selected evidence at this point of use [rollback]
  2. (diff | hist) 10:18 Talk:AmbioPharm 822 +378 NPOV_Nadia (talk | contribs) /* Notability, and what a long registry record does not establish */ reply
  3. (diff | hist) 09:26 Talk:Beyond-use date 1,233 +213 PlainNumbersPip (talk | contribs) /* Date arithmetic: inclusive or exclusive? */ reply
  4. (diff | hist) m b 08:23 Baseline laboratory panel 4,429 ±0 CategoryBot (talk | contribs) bot: normalise citation format [rollback]
  5. (diff | hist) 03:32 Proglucagon 6,709 ±0 BetaCellBoyd (talk | contribs) add the reference range with the assay it was established on [rollback]

2 October 2025

  1. (diff | hist) m 22:43 Liraglutide 5,967 ±0 CuriousCallum (talk | contribs) rm duplicated pharmacokinetics — the same figures appear in the infobox [rollback]
  2. (diff | hist) 16:11 Talk:Beyond-use date 1,022 +280 BUD_Bertram (talk | contribs) /* Date arithmetic: inclusive or exclusive? */ reply
  3. (diff | hist) 13:44 Talk:Beyond-use date 811 +369 UnitAuditUwe (talk | contribs) /* Date arithmetic: inclusive or exclusive? */ new section
  4. (diff | hist) 13:40 Talk:AmbioPharm 611 +374 COA_Colwyn (talk | contribs) /* Notability, and what a long registry record does not establish */ reply
  5. (diff | hist) 11:22 ChinaPeptides 13,591 ±0 UnderfillUna (talk | contribs) sentence case in headings per PP:MOS [rollback]
  6. (diff | hist) 09:15 Talk:AmbioPharm 400 +489 ScopeSeverin (talk | contribs) /* Notability, and what a long registry record does not establish */ new section
  7. (diff | hist) N 09:00 AmbioPharm 1,686 +1,686 RetinopathyRex (talk | contribs) start organisation article — registry facts and product scope only
  8. (diff | hist) 08:07 Active pharmaceutical ingredient 4,569 +214 PurityClaimPia (talk | contribs) add the year the guidance was issued [rollback]
  9. (diff | hist) m b 07:06 Dipeptidyl peptidase-4 7,022 ±0 StubSorterBot (talk | contribs) bot: flag bare reference [rollback]
  10. (diff | hist) 03:55 Cagrilintide 4,256 ±0 NewLabNell (talk | contribs) ce per PP:MOS [rollback]
  11. (diff | hist) m 01:14 Number needed to treat 4,718 ±0 NNT_Nerys (talk | contribs) name the funder in the sentence, per PP:MOS [rollback]

1 October 2025

  1. (diff | hist) 23:18 Loss on drying 4,874 ±0 Hedgerow_Hal (talk | contribs) give the injection volume, without which the loading cannot be judged [rollback]
  2. (diff | hist) m 23:04 GLP-1 receptor agonist 11,148 ±0 BatchNumberBede (talk | contribs) add category for the drug class [rollback]
  3. (diff | hist) m b 21:38 Methionine oxidation 5,001 +478 CiteBot (talk | contribs) bot: normalise citation format [rollback]
  4. (diff | hist) m b 20:41 FLOW trial 4,583 ±0 StubSorterBot (talk | contribs) bot: normalise trial registration identifier [rollback]
  5. (diff | hist) 20:30 GenScript Peptides 7,116 +767 COA_Colwyn (talk | contribs) rm the price; supplier articles carry no price per PP:VN [rollback]
  6. (diff | hist) 20:27 Syringe dead space 7,949 +2,030 UnitAuditUwe (talk | contribs) expand §Measurement and standards [rollback]
  7. (diff | hist) m b 16:38 Solid-phase peptide synthesis 5,359 ±0 CiteBot (talk | contribs) bot: sort category members [rollback]
  8. (diff | hist) 12:26 Research use only 7,990 +266 ExenatideEzra (talk | contribs) clarify the difference between a marketing authorisation and a registration [rollback]
  9. (diff | hist) 07:59 Wuhan Wansheng Biotechnology 15,629 +226 Chromatokid (talk | contribs) add the transit window each regional warehouse serves [rollback]
  10. (diff | hist) m b 04:54 Lyophilisation 28,089 +506 CategoryBot (talk | contribs) bot: sort category members [rollback]
  11. (diff | hist) 01:48 USP General Chapter 85 4,920 ±0 Ref_Desk_Ron (talk | contribs) fix indentation in the source [rollback]
  12. (diff | hist) m b 01:26 Injection site rotation 4,872 +246 CategoryBot (talk | contribs) bot: normalise citation format [rollback]
  13. (diff | hist) 00:04 Peptide synthesis 5,649 ±0 FootnoteFyfe (talk | contribs) correct the transit-time figure — the source gives a median, not a maximum [rollback]

30 September 2025

  1. (diff | hist) m b 23:02 Amino acid analysis 4,623 ±0 CategoryBot (talk | contribs) bot: normalise unit spacing [rollback]
  2. (diff | hist) 22:47 Shenzhen Hybio Pharmaceutical 7,111 ±0 EndotoxinEd (talk | contribs) state the city and province of the registered address [rollback]
  3. (diff | hist) m b 21:46 Sterility testing 4,776 ±0 StubSorterBot (talk | contribs) bot: flag bare reference [rollback]
  4. (diff | hist) 17:45 HOMA-IR 4,511 ±0 BaselineBex (talk | contribs) add the note that the marker changes with weight loss independently of the drug [rollback]
  5. (diff | hist) 16:41 Zhuhai Kerui Biotechnology 8,636 +357 ForgeryFinder (talk | contribs) rm the adjective — an organisation article describes, it does not praise [rollback]
  6. (diff | hist) 14:46 Shanghai Wibson Biotechnology 12,527 +1,119 HalfLifeHavel (talk | contribs) attribute the documentation description to the purchaser reports it comes from [rollback]
  7. (diff | hist) m 12:32 Trial data comparison 6,666 +143 GlossaryGleb (talk | contribs) expand the table so the third syringe scale is covered [rollback]
  8. (diff | hist) m 10:26 Customs seizure 4,516 ±0 Retention_Time_Rae (talk | contribs) name the regulator rather than writing "the authorities" [rollback]
  9. (diff | hist) 07:38 Peptide stability table 5,688 ±0 AppendixAlva (talk | contribs) the calculator rounded before dividing; corrected [rollback]
  10. (diff | hist) m 06:36 Liquid chromatography-mass spectrometry 4,463 +187 AAA_Analyst (talk | contribs) state the mass accuracy in parts per million rather than daltons [rollback]
  11. (diff | hist) 05:40 STEP trial programme 5,534 ±0 EndpointEnid (talk | contribs) add category for the trial programme [rollback]
  12. (diff | hist) 00:08 Vial 25,024 +1,722 SPPS_Sorrel (talk | contribs) clarify that the cake appearance is an indicator, not a specification [rollback]

29 September 2025

  1. (diff | hist) 23:51 Peptide supply chain 8,410 ±0 CrudePeptidePearl (talk | contribs) add the shelf temperature and the primary drying step to the cycle description [rollback]
  2. (diff | hist) m 15:28 TRIUMPH trial programme 4,703 +154 SafetySignalSid (talk | contribs) correct the endpoint hierarchy — that was a secondary endpoint [rollback]
  3. (diff | hist) 10:58 Glucagon 7,074 ±0 OralSemaOswin (talk | contribs) fix hyphenation per PP:MOS [rollback]
  4. (diff | hist) 00:54 Trifluoroacetate counterion 4,865 ±0 ShortageShona (talk | contribs) give the injection volume, without which the loading cannot be judged [rollback]

28 September 2025

  1. (diff | hist) m 17:00 PeptideMeter 4,925 ±0 VerifyFirstVida (talk | contribs) correct the description of how lot identifiers are assigned [rollback]
  2. (diff | hist) m b 16:41 Dose escalation schedule 4,993 +311 CategoryBot (talk | contribs) bot: normalise unit spacing [rollback]
  3. (diff | hist) m 13:59 Orforglipron 5,647 +274 RotationRosalind (talk | contribs) expand §Reported clinical findings [rollback]
  4. (diff | hist) 07:34 PolyPeptide Group (Hangzhou) 6,267 +207 ForgeryFinder (talk | contribs) sentence case in headings per PP:MOS [rollback]
  5. (diff | hist) 04:26 GenScript Peptides 6,349 ±0 LotTraceLuka (talk | contribs) rm the comparison with another supplier; there is no common basis for it [rollback]

27 September 2025

  1. (diff | hist) 20:35 Reconstitution of lyophilised peptides 5,761 ±0 ShortageShona (talk | contribs) ce, tighten prose [rollback]
  2. (diff | hist) m 15:45 SURMOUNT trial programme 5,021 +300 Peptide_Pete (talk | contribs) de-orphan [rollback]
  3. (diff | hist) m 13:12 SinoPep 9,594 +106 CostPerMgCory (talk | contribs) correct the other-designations row — those are trading variants, not subsidiaries [rollback]
  4. (diff | hist) 11:54 Arcuate nucleus 5,251 +234 DPP4_Dagmar (talk | contribs) expand §Relevance to incretin pharmacology [rollback]
  5. (diff | hist) 07:45 Medutest 5,018 ±0 VerifyFirstVida (talk | contribs) state that the report identifies the sample, not the shipment [rollback]
  6. (diff | hist) 07:12 Batch number 4,573 ±0 TallySheetTad (talk | contribs) fix hyphenation per PP:MOS [rollback]

26 September 2025

  1. (diff | hist) 23:41 Multi-dose vial 21,485 +996 RepackRadek (talk | contribs) rm the individualised advice — the article describes, it does not instruct [rollback]
  2. (diff | hist) 16:46 Receptor bias 4,477 ±0 Chromatokid (talk | contribs) correct the second-messenger pathway named in the lead [rollback]
  3. (diff | hist) 16:02 Melanotan II 4,374 ±0 TB500_Tarquin (talk | contribs) correct the residue numbering — the source numbers from the mature peptide [rollback]
  4. (diff | hist) 14:28 Third-party testing 7,489 ±0 ComparisonCato (talk | contribs) rm the ranking language; this wiki publishes no ranking [rollback]
  5. (diff | hist) 08:27 Fasting insulin 4,198 ±0 Retention_Time_Rae (talk | contribs) add the cross-link to the organ-function article [rollback]

25 September 2025

  1. (diff | hist) 22:15 Shanghai Sigma-Audley New Material Technology 13,175 ±0 SyringeSybille (talk | contribs) attribute the documentation description to the purchaser reports it comes from [rollback]
  2. (diff | hist) 19:58 Intention-to-treat analysis 4,963 ±0 NPOV_Nadia (talk | contribs) ce [rollback]
  3. (diff | hist) 19:49 Bachem Holding (Suzhou) 13,958 +1,024 SecondarySrc_Seb (talk | contribs) expand the product-scope row in the infobox [rollback]
  4. (diff | hist) 18:57 Preparative HPLC purification 4,882 ±0 ResinRhoswen (talk | contribs) expand §What follows the column [rollback]
  5. (diff | hist) 13:36 Syringe dead space 5,919 ±0 RotationRosalind (talk | contribs) move a stray full stop inside the reference [rollback]
  6. (diff | hist) m b 12:45 Dual incretin agonist 5,851 ±0 CategoryBot (talk | contribs) bot: expand DOI to full citation [rollback]
  7. (diff | hist) 12:10 Timeline of incretin therapeutics 4,460 ±0 ColumnOvenCoy (talk | contribs) state the substitution in one-letter code as well, per PP:MOS [rollback]
  8. (diff | hist) m b 10:34 Prescribing information 4,506 ±0 StubSorterBot (talk | contribs) bot: normalise citation format [rollback]
  9. (diff | hist) m 08:06 LEADER trial 4,799 ±0 LeaderLoic (talk | contribs) expand §Place in the evidence [rollback]
  10. (diff | hist) 01:59 Subcutaneous injection 5,293 ±0 GradientGus (talk | contribs) add the note about drawing air before withdrawal [rollback]

24 September 2025

  1. (diff | hist) 21:36 WuXi TIDES 16,214 +1,570 GreyMarketGreer (talk | contribs) serial comma per PP:MOS [rollback]
  2. (diff | hist) 17:08 List of GLP-1 receptor agonists 3,862 ±0 OrphanPageOrin (talk | contribs) add the citation column and fill the first ten rows [rollback]
  3. (diff | hist) 11:18 Shenzhen Hybio Pharmaceutical 7,111 +2,345 Chromatokid (talk | contribs) add the storage and handling guidance the organisation publishes [rollback]
  4. (diff | hist) m 08:45 Counterfeit peptide 5,229 +303 BlankVialBo (talk | contribs) clarify that agreement between certificate and report is a weak finding [rollback]
  5. (diff | hist) 06:37 Contraindications of incretin therapy 4,993 +151 GradientGus (talk | contribs) British spelling per PP:MOS [rollback]
  6. (diff | hist) 02:19 USP General Chapter 71 4,657 ±0 GradientGus (talk | contribs) split §Principle from §Practical limitations [rollback]
  7. (diff | hist) m 00:52 Hubei Jianxiang Bioscience 9,693 +819 Hedgerow_Hal (talk | contribs) label the reception tally as weak, self-selected evidence at this point of use [rollback]

23 September 2025

  1. (diff | hist) 21:51 VendorInvestigate 5,067 ±0 KarlFischerKit (talk | contribs) add the point that reports reaching this wiki are not a sample of anything [rollback]
  2. (diff | hist) 19:54 Test report forgery 5,391 ±0 MelanocortinMil (talk | contribs) state the date range the submitted set covers [rollback]
  3. (diff | hist) 10:29 Shanghai ERP Biotechnology 6,476 +144 BatchNumberBede (talk | contribs) correct the trading name — the short code and the legal name are different things [rollback]
  4. (diff | hist) m 06:36 Guangzhou JEEP Biotechnology 14,075 +226 BlankVialBo (talk | contribs) rm the comparison with another supplier; there is no common basis for it [rollback]
  5. (diff | hist) 04:09 Survodutide 5,445 +143 ExenatideEzra (talk | contribs) attribute the potency comparison to the head-to-head trial rather than to two separate ones [rollback]

22 September 2025

  1. (diff | hist) 19:41 Insulin syringe 4,944 ±0 MicrodoseMagnus (talk | contribs) the example withdrew more than the syringe holds; corrected [rollback]
  2. (diff | hist) 18:40 Reference standard 5,217 ±0 GradientGus (talk | contribs) add the repeatability figure with the number of injections [rollback]
  3. (diff | hist) 18:36 Bacterial endotoxin test 5,317 +229 ReceptorRhoda (talk | contribs) state that ultraviolet response is not uniform across impurities [rollback]
  4. (diff | hist) 18:12 Sigma-Aldrich (Shanghai) Trading 13,171 +136 EndotoxinEd (talk | contribs) fix a dangling clause [rollback]
  5. (diff | hist) m 15:28 Amylin receptor agonist 5,245 ±0 CuriousCallum (talk | contribs) rm the equipotency claim — the cited paper does not make it [rollback]
  6. (diff | hist) 12:20 Albumin binding half-life extension 6,399 ±0 TrialsTabitha (talk | contribs) add see also to the sister hormone [rollback]
  7. (diff | hist) m b 11:27 Reconstitution calculator 8,369 ±0 CategoryBot (talk | contribs) bot: normalise unit spacing [rollback]
  8. (diff | hist) 08:20 Talk:Lyophilisation 1,307 +151 StabilityStig (talk | contribs) /* Collapse temperature and Tg-prime are being used interchangeably */ reply
  9. (diff | hist) m 06:30 Exenatide 5,754 +223 CagriCass (talk | contribs) add the excipient list from the labelling [rollback]

21 September 2025

  1. (diff | hist) 22:32 Blind sampling 8,193 ±0 LotTraceLuka (talk | contribs) rm the inference from one report to a supplier [rollback]
  2. (diff | hist) 19:04 Growth hormone secretagogue 4,613 +118 EpitalonEoin (talk | contribs) expand §Material in research supply [rollback]